MicroPath visits Jafral Biosolutions

To initiate an up-scaled production of our outer membrane vesicle based vaccine, MicroPath PI Hanne Winther-Larsen visited our new industrial partner Jafral Biosolutions in Ljubljana, Slovenia (https://www.jafral.com). The project is a follow up both the University of Oslo SPARK Norway program and Research Council of Norway Milepæl program. On the one day program was a site visit of the Jafral R&D and GMP production facilities, and a thorough discussion of the pilot production line of the vaccine.